$25.01
-0.45[-1.77%]
At close: Apr 24
$25.01
0[0.00%]
After Hours: 4:37PM EDT
BridgeBio Pharma
(NASDAQ:BBIO)BridgeBio Pharma Stock (NASDAQ:BBIO), Earnings Estimates, EPS, and Revenue
BridgeBio Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.980
Quarterly Revenue Estimate
$1.6M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$9.3M
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | AM | BBIO | Q1 | -$0.92 | -$0.98 | — | — | $1.83M | $1.63M | — | — | Get Alert |
| 02/22/2024 | AM | BBIO | Q4 | -$0.92 | -$0.91 | -$0.96 | -5.49% | $1.87M | $6.23M | $1.75M | -71.99% | Get Alert |
| 11/02/2023 | AM | BBIO | Q3 | -$0.93 | -$0.81 | -$1.08 | -33.33% | $338.00K | $4.26M | $4.09M | -3.97% | Get Alert |
| 08/03/2023 | AM | BBIO | Q2 | -$0.83 | -$0.83 | -$0.98 | -18.07% | $73.75M | $2.99M | $1.64M | -45.12% | Get Alert |
| 05/04/2023 | AM | BBIO | Q1 | -$1.35 | -$0.83 | -$0.92 | -10.84% | $1.69M | $3.37M | $1.83M | -45.82% | Get Alert |
| 02/23/2023 | AM | BBIO | Q4 | -$1.01 | -$0.85 | -$0.92 | -8.24% | $12.89M | $4.52M | $1.87M | -58.63% | Get Alert |
| 11/03/2022 | AM | BBIO | Q3 | -$1.06 | -$0.99 | -$0.93 | 6.06% | $2.34M | $7.90M | $338.00K | -95.72% | Get Alert |
| 08/04/2022 | AM | BBIO | Q2 | -$0.66 | -$0.63 | -$0.81 | -28.57% | $54.02M | $16.07M | $73.75M | 358.90% | Get Alert |
| 05/05/2022 | AM | BBIO | Q1 | -$1.18 | -$1.11 | -$1.19 | -7.21% | $462.00K | $4.69M | $1.69M | -63.88% | Get Alert |
| 02/24/2022 | AM | BBIO | Q4 | -$1.01 | -$0.87 | -$1.01 | -16.09% | $122.00K | $21.58M | $12.89M | -40.29% | Get Alert |
| 11/04/2021 | AM | BBIO | Q3 | -$0.98 | -$0.90 | -$1.06 | -17.78% | $8.13M | $17.36M | $2.34M | -86.50% | Get Alert |
| 08/05/2021 | AM | BBIO | Q2 | -$1.03 | -$0.96 | -$0.66 | 31.25% | $0.00 | $29.12M | $54.02M | 85.52% | Get Alert |
| 05/06/2021 | AM | BBIO | Q1 | -$0.78 | -$0.80 | -$1.18 | -47.50% | $0.00 | $32.10M | $462.00K | -98.56% | Get Alert |
| 02/25/2021 | AM | BBIO | Q4 | -$0.62 | — | -$1.01 | — | $13.82M | — | $122.00K | — | Get Alert |
| 11/05/2020 | AM | BBIO | Q3 | -$0.51 | — | -$0.98 | — | $26.74M | — | $8.13M | — | Get Alert |
| 08/11/2020 | AM | BBIO | Q2 | -$0.71 | — | -$1.03 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/13/2020 | PM | BBIO | Q1 | -$0.66 | — | -$0.78 | — | — | — | $0.00 | — | Get Alert |
| 03/02/2020 | AM | BBIO | Q4 | — | -$0.70 | -$0.62 | 11.43% | — | — | $13.82M | — | Get Alert |
| 11/07/2019 | AM | BBIO | Q3 | -$0.52 | — | -$0.51 | — | — | — | $26.74M | — | Get Alert |
FAQ
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma (BBIO) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
What were the latest earnings per share (EPS) for BridgeBio Pharma (NASDAQ:BBIO)?
The Actual EPS was $-0.96, which missed the estimate of $-0.91.
What were BridgeBio Pharma’s (NASDAQ:BBIO) revenues?
The Actual Revenue was $1.7M, which missed the estimate of $6.2M.
Browse earnings estimates, EPS, and revenue on all stocks.